2012/07/24 by Kimberly A. Babson, James Sottile, Danielle M. Morabito +1 · 1 citation
Arts and Humanities · Mathematics · Medicine · Neuroscience · Psychology · #Anesthesia #Apnea #Cannabidiol #Cannabinoid #Cannabis #Cannabis and Cannabinoid Research #Dronabinol #Epistemology #Event (particle physics) #Historical Linguistics and Language Studies #Insomnia #Internal medicine #Language, Metaphor, and Cognition #Linguistics #Mathematics #Meaning (existential) #Medicine #Metaphysics #Obstructive sleep apnea #Philosophy #Philosophy of language #Point (geometry) #Polysomnography #Proposition #Psychiatry #Psychology #Sleep (system call) #Sleep and Wakefulness Research #Sleep and related disorders #Sleep apnea #Sleep disorder #Sleep onset latency #linguistics and terminology studies
paper · doi:10.1007/s11920-017-0775-9
openalex publication_date 2012/07/24 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/23
Preliminary research into cannabis and insomnia suggests that cannabidiol (CBD) may have therapeutic potential for the treatment of insomnia. Delta-9 tetrahydrocannabinol (THC) may decrease sleep latency but could impair sleep quality long-term. Novel studies investigating cannabinoids and obstructive sleep apnea suggest that synthetic cannabinoids such as nabilone and dronabinol may have short-term benefit for sleep apnea due to their modulatory effects on serotonin-mediated apneas. CBD may hold promise for REM sleep behavior disorder and excessive daytime sleepiness, while nabilone may reduce nightmares associated with PTSD and may improve sleep among patients with chronic pain. Research on cannabis and sleep is in its infancy and has yielded mixed results. Additional controlled and longitudinal research is critical to advance our understanding of research and clinical implications.